Esperion Therapeutics
ESPR
#7639
Rank
A$0.45 B
Marketcap
$2.31
Share price
-3.67%
Change (1 day)
-45.96%
Change (1 year)

EPS for Esperion Therapeutics (ESPR)

EPS in 2023 (TTM): -$4.23

According to Esperion Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.52. In 2022 the company made an earnings per share (EPS) of -$5.68 an increase over its 2021 EPS that were of -$15.31.

EPS history for Esperion Therapeutics from 2000 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$4.23-25.56%
2022-$5.68-62.87%
2021-$15.3180.38%
2020-$8.4950.14%
2019-$5.65-53.18%
2018-$12.077.41%
2017-$11.24110.81%
2016-$5.3347.35%
2015-$3.620.89%
2014-$3.5928.84%
2013-$2.78-89.3%
2012-$26.02
2002-$10.968.89%
2001-$10.07-83.77%
2000-$62.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$16.40 263.12%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.25-127.61%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.98-165.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$59.83-1,424.82%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.02-77.30%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.09-75.89%๐Ÿ‡บ๐Ÿ‡ธ USA